# DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy

> **NCT00429806** · PHASE1 · COMPLETED · sponsor: **CHU de Quebec-Universite Laval** · enrollment: 40 (actual)

## Conditions studied

- Vaginal Atrophy

## Interventions

- **DRUG:** DHEA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00429806
- **Lead sponsor:** CHU de Quebec-Universite Laval
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-03
- **Final completion:** 2007-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429806, "DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00429806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*